Former VP of Translational Sciences and Oncology Biomarkers with 20+ years spanning target discovery through Phase 1/2/3 biomarker strategy across multiple cancer indications. Background includes CDx development, genomics, spatial pathology, and high-impact peer-reviewed publications. Seeking to acq…
Former VP of Translational Sciences and Oncology Biomarkers with 20+ years spanning target discovery through Phase 1/2/3 biomarker strategy across multiple cancer indications. Background includes CDx development, genomics, spatial pathology, and high-impact peer-reviewed publications. Seeking to acquire and operate a life sciences services business as a scientific operator, not a financial buyer.
Financing
$5M
SBA preapproved
Target revenue
$2–8M
Annual
Timeline
ASAP
Ready to move
Structure
Full
Business acquisition only
Target business types
Biomarker services CRO
Genomics / sequencing lab
Translational science consultancy
Acquisition priorities
1 Existing client revenue
2 Lab infrastructure and equipment
3 Scientific team
4 Established biopharma relationships
Non-negotiables
✕ Client concentration above 40% from any single client
✕ Owner unwilling to support 12-24 month transition
✕ Revenue decline greater than 15% in the last 24 months
✕ Active litigation or unresolved compliance issues
✕ No documented SOPs
What I bring to the acquisition
Direct operator with VP-level biopharma credibility. Day one I elevate the business's scientific positioning, open doors to larger clients, and provide strategic oversight that most small services companies cannot access at any price. This is a legacy-preserving acquisition, not a financial extraction.
Team (1)
Sectors Omar Kabbarah, MSc, PhD serves:
Business Services
Energy & Utilities
Industrials
Consumer Services
Financial Services
Distribution
Health Care
Technology
Join Axial's Private M&A Platform
Omar Kabbarah, MSc, PhD connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
